
Chief GI Fellow @UFMedicineJax | Incoming Advanced IBD Fellow @NorthwesternU
Jacksonville, FL
Joined April 2021
- Tweets357
- Following180
- Followers650
- Likes2.2K
Pinned Tweet
Evolution of treatment targets in #IBD:
👉Stride 1 (2015)
👉Stride 2 (2021)
👉Stride 3 (2026)
Key differences, all in one table 👇
💩 Elevated fecal calprotectin does not always = #IBD activity
Other causes:
🦠 GI infections
💊 Medications (NSAIDs, PPIs)
🔬 Colorectal neoplasia
🔥 Other inflammatory GI conditions
🦴 Rheumatologic diseases
👶 Age-related elevations
👉 Interpret in the right clinical context
🚨New Nature Medicine study on Vedolizumab resistance in #UC:
👉4 distinct response patterns identified
👉Nonresponse linked to SPP1⁺ macrophages & vascular inflammation
👉ACEi/ARBs associated with improved outcomes & response to Vedo
👉More RCTs needed
nature.com/articles/s41591-0…
Antoine Boustany, MD, MPH, MEM retweeted
این مقاله نیوانگلند سر و صدا کرده و انتقادات بسیاری برانگیخته. پیشبینی کرده با توسعه AI چقدر از هر تخصص جایگزین میشه:
پاتولوژی کامل، بعد رادیولوژی و غدد و ۸۰٪ قلب
برعکس: ENT, جراحی کلورکتال و قلب و گوارش تقریبا آسیبی نمیبینند.
روانپزشکی ۱۲٪ آسیب میخورد
Antoine Boustany, MD, MPH, MEM retweeted
Management of C diff infection in patients with IBD - AGA Clinical Practice Update 2026
Two key studies in #IBD exploring elective appendectomy in the management of #UlcerativeColitis:
• ACCURE (2025)
• COSTA (2026)
Key differences summarized below 👇
With the rapid expansion of #IBD therapies, it is easy to lose track of which drugs are available and which are still in development
👉Understanding the different phases of clinical trials helps us make sense of what is coming next
Here is a simple visual summary 👇
My stepwise approach to #constipation:
1️⃣ Red flags, Medical Hx & Meds review 💊
2️⃣ Lifestyle/Dietary changes & Fibers 🍃
3️⃣ Osmotic laxatives 💦
4️⃣ Stimulant laxatives 💪
5️⃣ Secretaguogs +/- Prokinetics 🏹
6️⃣ Further tests❓
Antoine Boustany, MD, MPH, MEM retweeted
Diet matters for healthy high-risk first-degree relatives with persistent fecal calprotectin elevation and without overt Crohn's disease
New findings from the PIONIR (Preventing IBD ONset in Individuals at Risk) randomized controlled trial showed:
✅ The Tasty&Healthy diet led to a significant reduction in fecal calprotectin:
🔸 from baseline (61% lower)
🔸 compared with the habitual diet (37% lower)
✅ Fecal calprotectin rapidly increased after participants returned to their habitual diet
👉 The anti-inflammatory effect depends on continued dietary exposure
✅ The Tasty&Healthy diet was characterized by:
👉 higher intakes of potassium and fiber
👉 lower saturated fat intake
👉 no consumption of ultra-processed foods
💡 A shift toward a healthier, minimally processed, plant-based dietary pattern that may be protective in IBD
Don't underestimate the power of a whole-food diet can have in decreasing objective inflammation in people at high risk of IBD
📚 Read the full research article in @AGA_Gastro : pubmed.ncbi.nlm.nih.gov/4293…
Antoine Boustany, MD, MPH, MEM retweeted
Upadacitinib was linked to a lower risk of treatment failure than five other advanced therapies for #ulcerativecolitis, especially among patients who had used an advanced therapy in the previous 12 months, in a new study from @AGA_CGH.
➡️ow.ly/G8bh5101nEg
Antoine Boustany, MD, MPH, MEM retweeted
Does disease extent influence the efficacy of IL-23 inhibitors in UC?
Our new meta-analysis explores differential IL-23 inhibitor efficacy. 📝
Grateful to @IBD_GorenMD for his mentorship and our entire team for their contributions!
@UpstateGastro
tinyurl.com/mrmrxk5b
Antoine Boustany, MD, MPH, MEM retweeted
Especialidades con el mejor y peor balance en sus vida profesionales con su vida personal
Las mejores
✅️Dermatologia
✅️Alergias e Inmuno
✅️Gastroenterologia
✅️ #Psiquiatría
Las que más se dificulta
❌️Cirugía
❌️Urgencias
❌️Med Interna
medscape.com/p11/following-t…
Meta-analysis of 4,697 #IBD patients with #Crohn’s:
👉Evaluated clinical & endoscopic response
👉Ileal CD: Lowest clinical remission
👉Ileal CD: Best efficacy with GSK
👉Colonic CD: Best efficacy with Upa
👉Efficacy of therapy varied by location
academic.oup.com/ibdjournal/…
Antoine Boustany, MD, MPH, MEM retweeted
Ileum intubation:
9 to 11 o'clock: pull back, big wheel up, torque counterclockwise, air, big wheel down a bit.
6 to 7 o'clock: pull back slowly, big wheel down, air, big wheel down a bit, slight torque right.
Use water. Push gently.
Which is harder?
First #RCT in interventional #IBD comparing Endoscopic Stricturotomy vs Balloon Dilation @ibd_pal
👉106 #Crohn <3cm symptomatic stricture
👉Randomized ES vs EBD
ES had lower 1 year:
👉Clinical recurrence: 30.1% vs 54.7%
👉Reintervention: 24.5% vs 49.1%
cghjournal.org/article/S1542…
Interesting facts from Delphi Consensus on <20 mm polyp resection:
👉Photo documentation before and after resection
👉At least 1 mm margin resection
👉Use of near focus to inspect resection defect
👉Incomplete resection rate when >10 mm not exceeding 10%
cghjournal.org/article/S1542…
Antoine Boustany, MD, MPH, MEM retweeted
Esophageal ulcer, infection suspected:
HSV lives at the ulcer edge.
CMV lives in the ulcer base.
Take at least 6 biopsies: 3 edge, 3 base. Turn the scope to aim the forceps.
How many do you take?
🚨#FDA approves SC induction SKYRIZI for moderate to severe #Crohn’s disease
👉SKYRIZI becomes the second IL23 approved for SC induction in Crohn’s
👉Great results from phase 3 Affirm trial (60 vs 15% endoscopic response by week 12)
news.abbvie.com/2026-10-23-U…
#AI understands the data, Doctors understand the patient.
1
112


















